MHRA: Adaptive AI Technology to Advance NHS Healthcare

Healthcare professionals across the NHS are facing mounting pressures as demographic shifts and rising morbidity rates reshape the clinical landscape.

For practitioners working on the front lines, the challenge is not simply managing increased demand but fundamentally transforming how care is delivered.

The ageing population and persistent health inequalities require clinicians to adopt new approaches to service delivery.

However, the nationalised structure of the NHS offers a crucial advantage for those working to integrate emerging technologies into practice.

The coordinated infrastructure allows practitioners to implement innovations with consistent data standards, cybersecurity protocols and clinical guidelines that support rather than hinder their work.

Adapting to regulatory frameworks

For clinicians considering the adoption of AI tools, understanding the evolving regulatory landscape is essential.

The Medicines and Healthcare products Regulatory Agency (MHRA) is developing frameworks specifically designed for adaptive AI technologies that learn from real-world data, according to the agency's guidance on software and AI as medical devices.

Unlike traditional medical devices that remain static, these systems evolve as they encounter clinical scenarios, presenting both opportunities and challenges for practitioners.

The regulatory approach now emphasises lifecycle oversight, meaning clinicians must engage with both pre-deployment evaluation and ongoing post-market monitoring.

This transition requires healthcare professionals to think differently about technology adoption, recognising that safety, performance and equity must be assessed continuously rather than at a single point in time.

Monitoring performance in practice

Practitioners implementing AI applications face the complex task of ensuring these tools continue to perform effectively once integrated into clinical workflows.

Healthcare professionals must actively participate in monitoring whether models maintain their intended accuracy across diverse patient populations.

This involves comparing performance with alternative approaches and remaining vigilant for algorithmic bias that could compromise care quality.

Clinicians are uniquely positioned to identify when bias emerges, particularly if certain patient groups receive suboptimal recommendations.

Engaging with robust testing protocols allows practitioners to maintain standards of equitable treatment while benefiting from technological innovation.

Without this clinical oversight, there is a risk that advancing technology could inadvertently widen existing health disparities.

Dame Jennifer Dixon, CEO of the Health Foundation, says: “I am often struck by how complex and fragmented health care is in other countries.

“We have a national system, where coordinated strategic direction is more possible – such as for investment, regulation, payment incentives, price control, standards of clinical care and of course across data infrastructure and cybersecurity.

“Where 30 years ago the NHS might have seemed to reformers like a large elephant that was difficult to move, now it might just be that a national system with good coordination could come into its own as we try to respond and get ahead of a very rapidly developing technology to benefit the UK population.”

Integrating technology into workflows

For healthcare professionals, adopting new technology extends far beyond assessing its technical capabilities.

Practitioners must consider how AI applications fit within existing clinical workflows and whether they enhance rather than disrupt patient care.

This socio-technical integration requires evaluating whether tools are acceptable to clinical teams, fair to patients and safe when implemented in real-world settings where workarounds inevitably occur.

Clinicians must also consider broader implications such as shifts in care settings, time investment required for implementation and the practical return on effort.

Understanding these factors is crucial for practitioners advocating for or resisting particular innovations within their departments.

Healthcare professionals conducting local service evaluations face significant challenges in generating reliable evidence.

While formal research programmes maintain high standards, practitioners implementing technology at the local level often lack consistent evaluation frameworks.

Clinicians require formalised approaches to assess new tools rigorously before wider adoption.

Without standardised evaluation methods, there is a risk of overclaiming results, which erodes trust among clinical teams and patients alike.

Practitioners need robust local testing protocols that feed into broader surveillance systems, ensuring that evidence generated in clinical settings informs decisions about expanding technologies across the NHS and similar healthcare systems internationally.

Healthcare professionals must become more effective at signalling where technology can address their most pressing clinical needs.

Practitioners working directly with patients are best positioned to identify priority areas where innovation could improve outcomes.

By articulating these needs clearly, clinicians can help direct development toward genuine clinical challenges rather than technological solutions seeking problems.

This requires coupling demand signalling with faster, cost-effective testing that maintains high safety and equity standards.

Strengthening the connection between regulatory oversight, evidence generation and clinical implementation could support practitioners in delivering improved care while maintaining the trust essential to their work.